Picture of Nexstim Oyj logo

NXTMH — Nexstim Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Nexstim Gets FDA Clearance In U.S. For OCD Treatment

March 23 (Reuters) - Nexstim Oyj NXTMH.HE:

NBS SYSTEM 6 GAINS FDA CLEARANCE FOR TREATMENT OF OBSESSIVE COMPULSIVE DISORDER (OCD)

NBS 6 IS ALSO FDA-CLEARED FOR PRE-SURGICAL MAPPING OF SPEECH AND MOTOR CORTICES OF BRAIN

ANNOUNCES LAUNCH OF NBS 6 SYSTEM FOR TREATMENT OF OBSESSIVE COMPULSIVE DISORDER (OCD) IN UNITED STATES

Source text: (Full Story)

Further company coverage: NXTMH.HE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Nexstim Oyj

See all news